PRIME Education
@PRIME_cme
Followers
421
Following
262
Media
4K
Statuses
4K
PRIME is a healthcare education and research company advancing the science of learning and behavior change for 30 years. https://t.co/G3Bu7BKRFU
New York, NY
Joined October 2017
Join Us November 12th for this Live Webinar! Checkpoint, Claudin, and Beyond: Optimizing Biomarker-Driven Decisions in Advanced/Metastatic G/GEJ Cancer Care | 1-hour CME/CE | Register Today! #MedEd #cme #CancerCare | https://t.co/lAqudvODZC
0
0
0
Join our personalized learning experience with this AdaptiveMedEd Activity! Incorporating Recently Approved FLT3 Inhibitors as Maintenance Therapy for Patients with a History of FLT3-Mutation | 0.25-hour CME/CE | #MedEd #cme #Adaptivelearning | https://t.co/KKyO0LEpZ3
0
0
0
Up for a Challenge? | Evidence-Based Strategies for HRS Treatment: Drawing on Recent Clinical Data and Guidelines to Improve Outcomes CE | Clinical Case Challenge #2 of 2 in the HRS-AKI Accelerator Hub | #MedEd #cme #HepatorenalSyndrome | https://t.co/mjuqb7uE4G
0
0
0
Live National Webinar With Q&A Today, Register Now! | HER2 Beyond the Binary: Navigating HER2-Low and HER2-Ultralow Metastatic Breast Cancer | 1.0-hour CME/CE | #MedEd #cme #BreastCancer | https://t.co/WdQnyGwkpR
0
0
0
Check Out this AdaptiveMedEd Activity! eal-time feedback, targeted resources, and cutting-edge data await! Overcoming Barriers to Optimal Treatment and Management of FLT3-Mutated AML in the Frontline Setting | 0.25-hour CME/CE | #MedEd #cme | https://t.co/d39OHv8jqB
0
0
0
Stay ahead of the curve! | Optimizing Supportive Care and Management in Pediatric Low-Grade Glioma | 0.25-hour CME/CE | Clinical Case Challenge#2 of 2 | #MedEd #cme #Lowgradeglioma | https://t.co/SJEIFZgoEY
0
0
0
Register Now for Today's Live Webinar! Awaken to Better Care: Expert Strategies for Managing Narcolepsy, IH, and Common Comorbidities | 0.75-hour CME/CE #MedEd #cme #Narcolepsy | https://t.co/GpjiMbAQOK
0
0
0
See How You Stack Up! | Decoding HRS Diagnostic Criteria to Enhance Early Recognition and Improve Outcomes | 0.25-hour CME/CE | Clinical Case Challenge #1 of 2 in the HRS-AKI Accelerator Hub | #medEd #cme #hepatorenalsyndrome | https://t.co/WOX7pzEIOR
0
0
0
Start Your Personalized CME Journey Now! | Optimizing Immunotherapy in Early-Stage Triple-Negative Breast Cancer | 0.5-hour CME/CE | AdaptiveMedEd Activity | #MedEd #cme #EarlyStageBreastCancer #Adaptivelearning | https://t.co/iWzMKmz1Qy
0
0
0
Secure Your Spot for Oct 30! Live Clinical Connections Webinar | Multidisciplinary Strategies in Head and Neck Cancer: Biomarkers, Immunotherapy, and Adverse Event Management | 1.0-hour CME/CE | #MedEd #cme #HeadNeckCancer | https://t.co/7vmSeTsffv
0
0
0
Reserve Your Spot Today for this Live National Webinar Oct 29th! | What's Next in First-Line Treatment of mTNBC: Expert Perspectives on Emerging Therapeutics | 1.0-hour CME/CE | #MedEd #cme #mTNBC #BreastCancerTherapies | Register Now! https://t.co/X9foIGppYC
0
0
0
Start Your Personalized CME Journey Now! | Integrating Immunotherapy-Based Neoadjuvant and Adjuvant Therapy in Early-Stage Triple-Negative Breast Cancer | 0.5-hour CME/CE | AdaptiveMedEd Activity | #MedEd #cme #EarlyStageBreastCancer #Adaptivelearning | https://t.co/GeFj6wpEo5
0
0
0
Test Your Knowledge & Earn 0.25-hour CME/CE! | Applying Emerging Evidence for Targeting DNA Damage Repair Pathway Alterations in Metastatic Breast Cancer | Clinical Case Challenge #2 of 2 | #MedEd #cme #MetastaticBreastCancer | https://t.co/fncI5xfDpE
0
0
0
Up for a Challenge? | Optimizing Genetic Testing and Treatment Selection Among Patients with High-Risk, Early-Stage Breast Cancers | 0.25-hour CME/CE | Clinical Case Challenge #1 of 2 | #MedEd #cme #Earlystagebreastcancer #breastcancertesting | https://t.co/DCTxZwzsv0
0
0
0
Reserve Your Spot Today for this Live National Webinar Oct 29th! | What's Next in First-Line Treatment of mTNBC: Expert Perspectives on Emerging Therapeutics | 1.0-hour CME/CE | #MedEd #cme #mTNBC #BreastCancerTherapies | Register Now! https://t.co/X9foIGppYC
0
0
0
Secure Your Spot for Oct 30! Live Clinical Connections Webinar | Multidisciplinary Strategies in Head and Neck Cancer: Biomarkers, Immunotherapy, and Adverse Event Management | 1.0-hour CME/CE | #MedEd #cme #HeadNeckCancer | https://t.co/7vmSeTsffv
0
0
0
PH-ILD: Read our multi-accredited JMCP Supplement Article | Shining a Spotlight on Pulmonary Hypertension Associated With Interstitial Lung Disease Care: The Latest Advances in Diagnosis and Treatment |1.0-hour CME/CE | #MedEd #cme #PulmonaryHypertension | https://t.co/VOFsilkluw
0
0
0
Boost Your Nephrology Know-How | Advances in Hyperphosphatemia Treatment: Evaluating the Clinical Evidence for Phosphate-Lowering Therapies in CKD | 0.25-hour CME/CE | Booster Quiz, CKD Accelerator Hub | #MedEd #cme #HyperphosphatemiaTreatment #CKD | https://t.co/240njiQsYM
0
0
0
Nephrology Update: Tune in Today! | Navigating the Evolving Landscape of Phosphate-Lowering Therapies for Hyperphosphatemia in CKD | 0.5-hour CME/CE | On-Demand Video, CKD Accelerator Hub | #MedEd #cme #HyperphosphatemiainCKD | https://t.co/6utmhjLj9l
0
0
0
Test Yourself! | Applying the Latest Evidence to Guide Treatment of Pediatric Low-Grade Glioma | 0.25-hour CME/CE | Booster Quiz | #MedEd #cme #Lowgradeglioma | https://t.co/ZgDvkUE0QO
0
0
0